增殖性糖尿病视网膜病变玻璃体与血浆的Olink蛋白组学鉴定新型炎症分子内型
该研究用Olink平台对47例增殖性糖尿病视网膜病变(PDR)、26例无视网膜病变糖尿病患者和48例非糖尿病患者的配对玻璃体和血浆样本进行蛋白组学检测,发现PDR玻璃体蛋白组差异显著,碳酸酐酶家族成员升高;聚类分析识别出三种PDR分子内型,其中Cluster 3富集CCL/CXCL/IL6/IL18趋化因子及促炎通路,可能对应更严重表型。
要点
- PDR患者玻璃体蛋白组与无视网膜病变糖尿病及非糖尿病患者差异显著,碳酸酐酶家族成员升高。
- PDR玻璃体聚类分析识别出三种分子内型,Cluster 3富集CCL/CXCL/IL6/IL18及促炎通路。
- 血浆蛋白组在PDR组与其他组间差异较小,提示局部玻璃体蛋白特征更能反映PDR异质性。
核心结论
- PDR患者玻璃体蛋白组差异显著,碳酸酐酶家族成员是潜在治疗靶点。
- 玻璃体内型分析发现富集CCL/CXCL/IL6/IL18炎症通路的独特患者亚群,提示局部蛋白特征在PDR异质性和患者分层中的意义。
研究设计与样本
- 研究纳入47例PDR、26例Non_DR和48例Non_DM患者,采集配对玻璃体和血浆样本。
- 采用Olink平台13个panel检测1161种蛋白,进行基因集富集分析和K-means聚类分析。
主要发现
- PDR玻璃体蛋白组与Non_DR或Non_DM组相比差异显著,碳酸酐酶家族成员升高。
- PDR血浆蛋白组与其他两组差异较小。
- PDR玻璃体聚类分析识别出三种分子内型,Cluster 3富集CCL/CXCL/IL6/IL18趋化因子及促炎信号通路。
关键数值与推荐
- Olink平台包含13个panel、靶向1161种蛋白。
- 聚类分析基于玻璃体蛋白组谱识别出三个PDR分子内型。
- Cluster 3特征为CCL/CXCL/IL6/IL18趋化因子及促炎信号通路富集。
临床怎么用
- 玻璃体蛋白组学可用于PDR分子内型分型,识别富集炎症通路的患者亚群。
- 碳酸酐酶家族成员和CCL/CXCL/IL6/IL18通路可作为潜在治疗靶点研究方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize proteomic profiles and underlying biological processes in vitreous humor and plasma of patients with proliferative diabetic retinopathy (PDR), diabetic patients without retinopathy (Non_DR), and non-diabetes mellitus patients (Non_DM), and to identify the molecular endotypes within PDR patients. METHODS: Proteomic profiling of paired vitreous humor and plasma samples from 47 PDR patients, 26 Non_DR patients, and 48 Non_DM patients were conducted with Olink platform. The Olink platform includes 13 panels targeting 1161 proteins. Gene set enrichment analysis was applied for enriched pathways, and the K-means clustering method was used to identify different PDR clusters based on vitreous proteomic profiles. RESULTS: Proteomic analysis revealed significant differences in the vitreous humor of PDR patients compared to those in the Non_DR or Non_DM groups, with elevation of carbonic anhydrase (CA) family members as potential contributors to PDR pathophysiology. Plasma samples from PDR group exhibited less profound differences in proteomic profiles compared to the other two groups. Clustering analysis of PDR vitreous samples identified three distinct clusters as molecular endotypes of PDR patients. Of those, Cluster 3 was characterized by enrichment in CCL/CXCL/IL6/IL18 chemokines and pro-inflammatory signaling pathways, which may contribute to more severe PDR phenotypes. CONCLUSIONS: Significant differences in proteomic profiles were observed in PDR patients, especially in vitreous samples, with CA family members identified as potential therapeutic targets for PDR. Endotyping analysis of vitreous samples uncovered unique patient population with enriched CCL/CXCL/IL6/IL18 inflammatory pathways, highlighting the significance of local protein signature changes in PDR disease heterogeneity and its potential applications in patient stratification and therapeutic treatment.
引用
- Lv K, Peng J, Wang H, et al. Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype. Invest Ophthalmol Vis Sci. 2026. PMID: 41563014. doi:10.1167/iovs.67.1.47
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。